Event | Aspart vs lispro | Glulisine vs lispro | Glulisine vs aspart |
---|---|---|---|
Total Mortality | 1.23 [0.98, 1.53] | 0.65 [0.41, 1.53] | 0.53 [0.35, 0.8]* |
CHD | 0.96 [0.82, 1.12] | 1.03 [0.79, 1.36] | 1.08 [0.85, 1.35] |
Fatal CHD | 1.17 [0.79, 1.74] | 1.04 [0.50, 2.16] | 0.89 [0.47, 1.67] |
CVD | 0.95 [0.82, 1.09] | 1.03 [0.80, 1.31] | 1.08 [0.88, 1.33] |
Fatal CVD | 1.15 [0.80, 1.66] | 0.88 [0.44, 1.78] | 0.77 [0.41, 1.42] |
Stroke | 0.94 [0.67, 1.34] | 0.33 [0.16, 0.66]* | 0.34 [0.18, 0.65]* |
Heart Failure | 1.00 [0.82, 1.23] | 0.76 [0.50, 1.13] | 0.75 [0.53, 1.08] |
Kidney Failure | 0.88 [0.68, 1.13] | 0.71 [0.42, 1.20] | 0.81 [0.50, 1.30] |
Hypoglycaemia | 1.42 [0.83, 2.44] | 1.30 [0.55, 3.10] | 0.92 [0.45, 1.85] |
Hyperglycaemia | 1.97 [1.01, 3.85]* | 1.88 [0.66, 5.33] | 0.96 [0.42, 2.18] |